GENE ONLINE|News &
Opinion
Blog

Alexion Pharmaceuticals
GeneOnline’s Weekly News Highlights: July 24-28
2023-08-01
Alexion Snaps Up LogicBio Seeking Expansion into Genomic Medicines
2022-10-03
China’s CANbridge Reports Positive Phase 1 Data of Contender to AstraZeneca’s Complement Inhibitor
2022-02-08
AstraZeneca Acquires Caelum in $500m Deal to Strengthen Rare Diseases Division
2021-09-30
BridgeBio Bags First FDA Nod with Rare Disease Drug Acquired from Alexion
2021-03-03
GeneOnline’s Top Mergers and Acquisitions of 2020
2020-12-30
AstraZeneca to Acquire Alexion for US$ 39 Billion to Grow Immunology Pipeline
2020-12-13
Taiwanese Government Grants 16 Million to aid Adimmune’s COVID-19 Vaccine Trials
2020-10-24
Efforts Behind the Taiwan Model of Combating COVID-19 Pandemic
2020-07-26Partner
Weekly in Asia|Nov-1
2019-11-19
LATEST
Bayer’s NUBEQA: Breakthrough in Prostate Cancer with 46% Risk Reduction and Future FDA Expansion Plans
2024-09-19
Highlights from ESMO 2024: Key Oncology Advances from Major Pharmaceutical Companies
2024-09-19
Five Biotech Stocks Soar: Eyes on Halozyme, United Therapeutics, Harmony, Ligand, and ADMA
2024-09-19
Biotech Industry Trends in 2024: A Look at the Billions in Oncology Deals
2024-09-18
Thailand’s Biotech Boom: Innovations in Precision Medicine, Cell Therapy, and Wellness Drive APAC Leadership
2024-09-18
International Green Party Showcases AI Solutions for a Healthy and Sustainable Future
2024-09-16
Bio Asia Pacific 2024 Close ASEAN Collaborations: Catalyzing Innovation and Global Partnerships
2024-09-12
EVENT
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
Scroll to Top